Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2001
10/10/2001EP1141314A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
10/10/2001EP1141313A2 Improved expression of hiv polypeptides and production of virus-like particles
10/10/2001EP1141311A1 Protective antigen of group a streptococci (spa)
10/10/2001EP1141309A1 Streptococcal abc transporter protein
10/10/2001EP1141308A2 Group b streptococcus proteins, and their use
10/10/2001EP1141306A2 Streptococcus antigens
10/10/2001EP1141296A2 Interferon-epsilon
10/10/2001EP1141288A2 Lymphocytic membrane proteins
10/10/2001EP1141278A2 Therapeutic phosphodiesterase inhibitors
10/10/2001EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy
10/10/2001EP1141268A2 $i(A. FUMIGATUS) ACETYL COENZYME-A CARBOXYLASE GENES AND POLYPEPTIDES AND USES THEREOF
10/10/2001EP1141240A1 Use of cd40 engagement to alter t cell receptor usage
10/10/2001EP1141235A2 (bifidobacterium) in the treatment of inflammatory disease
10/10/2001EP1141027A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
10/10/2001EP1141015A1 Insulin-like growth factor (igf) i mutant variants
10/10/2001EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response
10/10/2001EP1140999A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
10/10/2001EP1140998A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
10/10/2001EP1140997A2 Chlamydia trachomatis antigens
10/10/2001EP1140995A2 Peptides for inhibiting hbv core proteins
10/10/2001EP1140994A1 Outer surface proteins, their genes, and their use
10/10/2001EP1140993A1 Glycopeptide derivatives and pharmaceutical compositions containing the same
10/10/2001EP1140992A1 Cyclic peptide antifungal agents having a sugar substituent
10/10/2001EP1140991A1 Cyclic peptide antifungal agents
10/10/2001EP1140989A1 Alpha(v) beta(6) integrin inhibitors
10/10/2001EP1140988A1 Halovir, an antiviral marine natural product, and derivatives thereof
10/10/2001EP1140987A1 Peptides for inhibiting hpv e6 proteins
10/10/2001EP1140986A1 Pseudopeptide, synthesis method, reagent and applications
10/10/2001EP1140983A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors
10/10/2001EP1140978A1 Methods of identifying antigen gene sequences
10/10/2001EP1140966A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
10/10/2001EP1140965A1 Protonated/acidified nucleic acids and methods of use
10/10/2001EP1140962A2 Novel derivatives from the class of oleandomycin
10/10/2001EP1140958A1 Anti-(retro)viral conjugates of saccharides and acetamidino or guanidino compounds
10/10/2001EP1140952A1 Organo-phosphorus compounds and their utilization
10/10/2001EP1140943A2 Substituted pyrroloindoles
10/10/2001EP1140939A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods
10/10/2001EP1140937A2 Antiviral nucleoside analogues
10/10/2001EP1140932A1 1,8-benzonaphthyridine derivatives
10/10/2001EP1140920A1 Piperidines as ccr5 modulators
10/10/2001EP1140913A1 Thiourea inhibitors of herpes viruses
10/10/2001EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
10/10/2001EP1140900A2 Pyrazole compounds and uses thereof
10/10/2001EP1140895A2 Thiopyran compounds as inhibitors of mmp
10/10/2001EP1140891A1 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments
10/10/2001EP1140880A1 Homopiperazine derivatives as selective emopamil inhibitors
10/10/2001EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001EP1140851A1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
10/10/2001EP1140850A1 Quinolinecarboxamides as antiviral agents
10/10/2001EP1140848A2 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity
10/10/2001EP1140846A1 Aspartic protease inhibitors
10/10/2001EP1140822A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
10/10/2001EP1140821A1 Lactams
10/10/2001EP1140805A1 Amido polybiguanides and the use thereof as antimicrobial agents
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140201A2 Compounds for intracellular delivery of therapeutic moieties to nerve cells
10/10/2001EP1140199A1 Hyaluronate lyase used for promoting penetration in topical agents
10/10/2001EP1140174A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines
10/10/2001EP1140170A1 Novel agents and methods for treatment and diagnosis of ocular disorders
10/10/2001EP1140166A2 Novel adjuvant for subunit or component vaccines
10/10/2001EP1140164A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/10/2001EP1140163A2 Combination of hepatitis b vaccine with antiviral agents
10/10/2001EP1140162A2 Vaccination method for efficient induction of cytotoxic t lymphocyte response
10/10/2001EP1140161A1 Synthetic virus-like particles with heterologous epitopes
10/10/2001EP1140160A2 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans
10/10/2001EP1140159A1 Oral vaccine against diarrhea
10/10/2001EP1140158A2 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
10/10/2001EP1140157A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
10/10/2001EP1140156A2 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
10/10/2001EP1140155A1 Improved recombinant hepatitis b surface antigen
10/10/2001EP1140152A1 Method to produce inactivated w/o emulsion adjuvated vaccines
10/10/2001EP1140143A2 Ribavirin-pegylated interferon alfa induction hcv combination therapy
10/10/2001EP1140142A2 Treatment of hepatitis c virus infections with interleukin-10
10/10/2001EP1140117A2 Aciclovir compositions containing dimethicone
10/10/2001EP1140114A2 Pharmaceutical formulations
10/10/2001EP1140113A2 Use of bisphosphonates for the prevention and treatment of infectious processes
10/10/2001EP1140091A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal consitions
10/10/2001EP1140085A1 Azabicycloalkanes as ccr5 modulators
10/10/2001EP1140083A1 Novel compounds
10/10/2001EP1140077A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
10/10/2001EP1140075A1 Treatment of retroviral infections with oxyphenbutazone
10/10/2001EP1140072A1 Compounds and methods
10/10/2001EP1140069A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
10/10/2001EP1140067A1 Antiviral method using mek inhibitors
10/10/2001EP1140066A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
10/10/2001EP1140058A1 N-formyl hydroxylamine derivatives as antibacterial agents
10/10/2001EP1140048A2 Methods for treating certain diseases using naaladase inhibitors
10/10/2001EP1140045A2 Homer a new target of treating psychiatric disorders
10/10/2001EP1140033A2 Improved controlled release compositions and method
10/10/2001EP1140027A1 Dosage forms comprising porous particles
10/10/2001EP1140021A1 Improved formulation for topical non-invasive application in vivo
10/10/2001EP1140020A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
10/10/2001EP1140019A1 Aerosol formulations for buccal and pulmonary application
10/10/2001EP1139913A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
10/10/2001EP1139762A1 Hydrogen peroxide disinfectant with increased activity
10/10/2001EP1139755A2 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
10/10/2001EP1083172A4 N-substituted derivatives of 5-oxyiminobarbituric acid
10/10/2001EP0922044B1 Pyrrolo(3,2-c) quinoline derivatives
10/10/2001EP0840620B1 Il-8 antagonists for treatment of asthma
10/10/2001EP0830372B1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
1 ... 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 ... 1798